Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- E2D, E5/Q&A Reach Step 4, Q5E, E2E Step 2: ICH-6
November 24, 2003
- BULLETIN
November 24, 2003
- A 4%-Combined Reduction in Medical Fees, NHI Prices Called for by MOF
November 24, 2003
- WORLD NEWS IN BRIEF
November 24, 2003
- In Transition from Old Products to New Introductions: Prof. Hohbach of NBI
November 24, 2003
- BUSINESS NEWS IN BRIEF
November 24, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 24, 2003
- Kirin Preparing for Fully Independent Marketing from 2005
November 24, 2003
- MEDICAL DEVICE NEWS IN BRIEF
November 24, 2003
- 9-month Business Results
November 24, 2003
- DIAGNOSTIC NEWS IN BRIEF
November 24, 2003
- Toyama Chemical: Business Hit by Delay in TTP's Marketing Activities
November 24, 2003
- OTC NEWS IN BRIE
November 24, 2003
- Taisho: Synergistic Effect of Integration Not Yet Seen
November 24, 2003
- Soiken to Develop Biomarkers for Fatigue
November 17, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 17, 2003
- Drugstore Chains Using Weather Derivatives to Avoid Risk
November 17, 2003
- Basic Policy for Next NHI Pricing Reform Proposed to Chuikyo Subcommittee
November 17, 2003
- Banyu Presents 1st Report on Its Large Japanese Study on Nu-Lotan
November 17, 2003
- NEW PRODUCTS
November 17, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…